Siemens sells clinical microbiology biz to Beckman Coulter

July 17, 2014 by Arezu Sarvestani

Beckman Coulter picks up Siemens Healthcare Diagnostics' clinical microbiology business in a closed-doors deal.

Siemens sells clinical microbiology biz to Beckman Coulter

Danaher (NYSE:DHR) subsidiary Beckman Coulter (NYSE:BEC) announced today that it signed a definitive agreement to acquire the clinical microbiology division of Siemens Healthcare (NYSE:SI).

The deal, the terms of which were not disclosed, is slated to close in the 1st quarter of 2015. Beckman hopes the acquisition will diversity its existing diagnostics business and drive growth for the company.

Sign up to get our free newsletters delivered right to your inbox.

The clinical microbiology division comes with an installed base of more than 6,000 instruments worldwide, according to a press release. The produce line includes the MicroScan suite of instruments and panels/consumables that Beckman says "are recognized in their industry for their high accuracy and superior detection of emerging resistance."

Comments